Topic
Stéphane Bancel
Stéphane Bancel is the chief executive of Moderna, and this page collects what he and others said about him on podcasts covering his career, Moderna's early years, the Covid vaccine and mRNA cancer treatments. Speakers include Luke Timmerman, Nicolai Tangen and a16z's Raising Health.
Bancel told Nicolai Tangen he realised at Davos in January 2020 that the virus would become a pandemic like 1918, and made Covid-19 Moderna's top priority. He told Luke Timmerman that he graduated from Harvard Business School in May 2000 and joined Eli Lilly. Peter McCullough told Joe Rogan that Bancel once told his wife Moderna had less than a 5% chance of succeeding.
27 facts from 5 episodes, in date order. These are what speakers said on the shows, each linked to the moment it was said. They aren't independently verified.
1990s
After a master's in biochemical engineering at Minnesota, Stéphane Bancel moved to Tokyo and lived there for almost four years working for bioMérieux.
“And so I went from Minnesota straight to Tokyo. And I lived in Tokyo for almost four years.”
Stéphane Bancel · Ep11: Stephane Bancel, 0:10:18
2000
Stéphane Bancel graduated from Harvard Business School in May 2000, when the Nasdaq peaked, and then joined Eli Lilly instead of a dot-com company.
“I graduated in May 2000 which as you know is when the Nasdaq peaked”
Stéphane Bancel · Ep11: Stephane Bancel, 0:13:29
2000s
As Eli Lilly's country manager for Belgium, Stéphane Bancel helped launch Alimta, Cymbalta and Cialis.
“we launched new products like Alimta for cancer, Cymbalta for CNS. We launched Cialis which was a really fun product to launch”
Stéphane Bancel · Ep11: Stephane Bancel, 0:19:53
2000s
Stéphane Bancel was 32 when Alain Mérieux first raised the idea of him becoming CEO of bioMérieux.
“of course you are way too young to have a chance I was 32 at the time to have a chance”
Stéphane Bancel · Ep11: Stephane Bancel, 0:20:47
2000s
Bancel says bioMérieux operated in 42 countries, with about 10 plants and 10 or 11 labs, while he was CEO.
“We had presence in 42 countries. So we had teams in 42 countries. I think 10 plants around the world, 10 or 11 labs around the world.”
Stéphane Bancel · Ep11: Stephane Bancel, 0:24:03
2011
Bancel says Moderna's first financing rounds before the AstraZeneca deal were $2 million, $2 million, $7 million and $25 million.
“The first round of Moderna, everybody forgets, was $2 million. The A of Moderna was $2 million. The B was $7 million. And the C was $25 million.”
Stéphane Bancel · Ep11: Stephane Bancel, 0:50:36
2011
Peter McCullough said Moderna CEO Stephane Bancel was on record telling his wife there was less than a 5% chance Moderna would succeed.
“he's on record telling his wife, Listen, there's probably less than 5% chance this will ever be successful.”
Peter McCullough · #2576 - Dr. Peter McCullough, 0:15:37
2012
Bancel had Moderna test two drugs in monkeys at once so that investors and pharma partners could not dismiss a single success as luck.
“we tried two drugs in Monkey at the same time because I told myself if we do only one, everybody is going to tell me”
Stéphane Bancel · Ep11: Stephane Bancel, 0:37:18
2012
Bancel set Moderna's early team a goal of making 100 different proteins in mice, a number he says he picked arbitrarily.
“I asked them to do 100 different proteins in mice.”
Stéphane Bancel · Ep11: Stephane Bancel, 0:37:56
2012
Bancel says he first met AstraZeneca CEO Pascal Soriot at a three-hour breakfast in December 2012 during the partnership talks.
“he set up a breakfast in Gettysburg with Pascal in December of 2012. And so I met Pascal for the first time.”
Stéphane Bancel · Ep11: Stephane Bancel, 0:46:16
2013
Bancel says Moderna's cash grew from about $20 million in March 2013 to about $500 million by mid-January 2014.
“we went from March 1st of 2013 with literally $20 million in the bank to January 15th JP Morgan 2014 $500 million in the bank”
Stéphane Bancel · Ep11: Stephane Bancel, 0:54:26
2014
Bancel says that when he surveyed Silicon Valley companies about onboarding, Netflix's took two hours while Facebook's took five weeks.
“from Netflix where the onboarding was two hours where you had Facebook where it was five weeks”
Stéphane Bancel · Ep11: Stephane Bancel, 1:02:54
2017
Stéphane Bancel says Moderna put six new drugs into clinical trials in 2017, bringing its total to 10 in the clinic.
“We put six new drugs in clinical trial. So today we have 10 drugs in clinical trial, which is a great number”
Stéphane Bancel · Ep11: Stephane Bancel, 0:05:17
2017
Bancel says Moderna spends roughly $100 million per year on its core platform, including process innovation and formulation.
“We need to fund the platform, give or take 100 million bucks per year.”
Stéphane Bancel · Ep11: Stephane Bancel, 0:57:21
2019
Stephane Bancel says he first learned of a new pneumonia-like disease in Wuhan, China from a Wall Street Journal article read on holiday in the south of France just after Christmas 2019.
“And there was a Wall Street Journal article that I read when I was actually in the south of France on vacation just a few days after Christmas 2019”
Stephane Bancel · Stephane Bancel CEO of Moderna, 0:00:37
2020
Bancel says he realised at Davos in the week of January 20, 2020 that the virus would be a pandemic like 1918, and he then made COVID-19 Moderna's top priority.
“It's only when I'm in Davos the week of January 20 that I realized that this was going to be a pandemic like 1918.”
Stephane Bancel · Stephane Bancel CEO of Moderna, 0:01:45
2020
Moderna CEO Stéphane Bancel previously appeared on the a16z podcast in December 2020 to discuss Moderna's mRNA COVID-19 vaccine.
“Stéphane joined us on the a16z podcast back in December of 2020 when we were talking about all of the work Moderna did to bring us the mRNA COVID vaccine.”
Jorge Conde · Moderna CEO Stéphane Bancel on the Next Era of mRNA, 0:02:20
2023
Moderna CEO Stéphane Bancel agreed to testify at a Senate HELP Committee hearing, led by Bernie Sanders and scheduled for March 22, about the planned Covid vaccine price increase.
“touting that Moderna CEO Stefan Boncel had agreed to appear and testify in a hearing sort of hilariously titled, taxpayers paid billions for it.”
Meg Terrell · 246: Vas Narasimhan on the future of pharma, plus Moderna’s promise & a biotech presidential bid, 0:03:09
Undated
Bancel says about two-thirds of human proteins act inside cells and only about a third enter the bloodstream, which was the part biotech drugs had mainly reached.
“around two-thirds of a human protein, a proteome, are intracellular protein. It's only a third that goes into the bloodstream”
Stéphane Bancel · Ep11: Stephane Bancel, 0:30:27
Undated
Bancel says he was raised by the Jesuits, which gave him a serving mindset that shaped his career in life science.
“I was raised by the Jesuits so kind of a serving mindset I've been in life science all my life”
Stephane Bancel · Stephane Bancel CEO of Moderna, 0:02:17
Undated
Bancel says he and his wife have started two foundations, which his wife runs.
“We have now actually two foundations that we've started that my wife is running.”
Stephane Bancel · Stephane Bancel CEO of Moderna, 0:15:15
Undated
Bancel previously ran BioMérieux, a French diagnostics company built by the Mérieux family.
“I used to run BioMérieux. It's a French-based diagnostic company. It was built by a family, the family of Marieux.”
Stephane Bancel · Stephane Bancel CEO of Moderna, 0:17:46
Undated
Stéphane Bancel said the cancer vaccine field had run more than a thousand clinical trials over 20-plus years that had all failed.
“The field, as you know, has been doing that for 20 plus years. I think more than a thousand clinical trials that have all failed.”
Stéphane Bancel · Moderna CEO Stéphane Bancel on the Next Era of mRNA, 0:04:31
Undated
Bancel said published Phase 3 data show only about 60% of patients are disease-free five years after Keytruda treatment.
“only 60 % of people are disease-free after five years. If you look at the phase three published data of Ketudra.”
Stéphane Bancel · Moderna CEO Stéphane Bancel on the Next Era of mRNA, 0:07:32
Undated
Bancel said that patients treated with checkpoint inhibitors such as Keytruda commonly develop autoimmune conditions including type 1 diabetes, lupus and Crohn's disease.
“people that get checkpoints, whether it's Ketudra or any other type of checkpoints from other companies, they end up having type 1 diabetes, lupus, Crohn disease, these type of things.”
Stéphane Bancel · Moderna CEO Stéphane Bancel on the Next Era of mRNA, 0:07:57
Undated
Bancel said that mRNA injected into muscle travels to the lymph nodes and enters antigen-presenting cells, which are key immune cells.
“the mRNA goes down to your lymph node and enters the APCs, the antigen presenting cell, which, as you know, are key components of your immune cells.”
Stéphane Bancel · Moderna CEO Stéphane Bancel on the Next Era of mRNA, 0:12:42
Undated
Bancel said the current version of intismeran is the worst version that will ever exist, and that Moderna plans to improve the algorithm using Phase 3 data.
“the worst version of Intismeran you're going to see for the rest of medical history”
Stéphane Bancel · Moderna CEO Stéphane Bancel on the Next Era of mRNA, 0:18:03